Skip to content
8-K

Material Event

American Oncology Network, Inc.

0001140361-23-054696

← back to feed
Filed
Nov 27, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Capex 2022 · Dec 31, 2022 $7.19M
Capex 2021 · Dec 31, 2021 $8.32M
Capex 2020 · Dec 31, 2020 $12.22M
Operating Cash Flow 2022 · Dec 31, 2022 −$6.78M
Operating Cash Flow 2021 · Dec 31, 2021 −$26.34M
Operating Cash Flow 2020 · Dec 31, 2020 $37.25M
Long Term Debt 2022 · Dec 31, 2022 $80.3M
Long Term Debt 2021 · Dec 31, 2021 $63.69M
Cash And Equivalents 2022 · Dec 31, 2022 $26.93M
Cash And Equivalents 2021 · Dec 31, 2021 $27.35M
Current Liabilities 2022 · Dec 31, 2022 $140.94M
Current Liabilities 2021 · Dec 31, 2021 $119.34M
Total Liabilities 2022 · Dec 31, 2022 $264.21M
Total Liabilities 2021 · Dec 31, 2021 $188.75M
Current Assets 2022 · Dec 31, 2022 $242.02M
Current Assets 2021 · Dec 31, 2021 $208.28M
Total Assets 2022 · Dec 31, 2022 $326.23M
Total Assets 2021 · Dec 31, 2021 $248.3M
Eps Diluted 2022 · Dec 31, 2022 $0.00
Eps Diluted 2021 · Dec 31, 2021 $0.00
Eps Diluted 2020 · Dec 31, 2020 $0.00
Eps Basic 2022 · Dec 31, 2022 $0.00
Eps Basic 2021 · Dec 31, 2021 $0.00
Eps Basic 2020 · Dec 31, 2020 $0.00
Sga Expense 2022 · Dec 31, 2022 $89.89M
Sga Expense 2021 · Dec 31, 2021 $77.05M
Sga Expense 2020 · Dec 31, 2020 $44.03M
Net Income 2022 · Dec 31, 2022 $2.59M
Net Income 2021 · Dec 31, 2021 −$105K
Net Income 2020 · Dec 31, 2020 $21.95M
Operating Income 2022 · Dec 31, 2022 $5.57M
Operating Income 2021 · Dec 31, 2021 $911K
Operating Income 2020 · Dec 31, 2020 $22.07M
Cost Of Revenue 2022 · Dec 31, 2022 $1.05B
Cost Of Revenue 2021 · Dec 31, 2021 $865.79M
Cost Of Revenue 2020 · Dec 31, 2020 $658.64M
Revenue 2022 · Dec 31, 2022 $1.15B
Revenue 2021 · Dec 31, 2021 $943.75M
Revenue 2020 · Dec 31, 2020 $724.74M